Patients aged 55 and younger were found to have worse pain, function and quality of life following total knee arthroplasty compared to patients 75 years and older, according to a study presented at the 2023 Annual Meeting of the American Academy of Orthopaedic Surgeons that looked at age-related differences in patient outcomes following TKA.
MRM Health provided a business update on its different ongoing therapeutic programs and an outlook for 2023.
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced that Noema Pharma, has raised an oversubscribed CHF 103 million Series B financing round.
BioMarin Pharmaceutical Inc. today announced that it received notice this afternoon from the U.S. Food and Drug Administration (FDA) that the agency has extended review of the company’s Biologics License Application (BLA) for ROCTAVIAN™ (valoctocogene roxaparvovec) gene therapy for adults with severe hemophilia A.
The U.S. Food and Drug Administration has accepted, for review, the supplemental Biologics License Application for Dupixent® to treat adults and adolescents aged 12 years and older with chronic spontaneous urticaria that is not adequately controlled with the current standard of care, H1 antihistamine treatment.
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the U.S. Food and Drug Administration has accepted for review the supplemental Biologics License Application for Dupixent® to treat adults and adolescents aged 12 years and older with chronic spontaneous urticaria that is not adequately controlled with the current standard of care, H1 antihistamine treatment.
En una investigación reciente, se ha analizado la resistencia al deslizamiento de diferentes pavimentos utilizados en carriles para bicicletas El estudio lo ha realizado el equipo de David Llopis Castelló, de la Universidad Politécnica de Valencia (UPV) en España …
Transcarent will get 98point6’s self-insured employer business, affiliated physician group and a software license. Meanwhile, 98point6 will rebrand as 98point6 Technologies and focus on licensing its software to third-party providers.
Transcarent to acquire majority of telehealth platform 98point6 for $100M Read More »
El feocromocitoma es un tumor raro, con una incidencia de tres a ocho casos por millón de habitantes cada año. El mayor estudio genómico realizado hasta ahora del feocromocitoma identifica a los pacientes con más riesgo de metástasis y a los que responder& …
Hallazgos sobre el feocromocitoma, un cáncer raro Read More »
While the extra time to comply is aimed at preventing medical device shortages, the rules have still left some device makers and certifying bodies unclear about how to proceed, says one attorney.
Medtech industry relieved as Europe’s MDR extension nears final approval Read More »
